您好,欢迎来到科研在线!科研采购 · 选型 · 实验方法
首页产品库品牌馆产品类别品牌新闻会议会展产品试用求职招聘资讯专题教程
PRO / Antibodies

In Vivo Star Anti-Mouse PLVAP/PV-1 Antibody

In Vivo Star Anti-Mouse PLVAP/PV-1 Antibody

英诺赛图(InnoCyto)的 In Vivo Star Anti-Mouse PLVAP/PV-1 Antibody(克隆 MECA-32) 为大鼠源 IgG2a Kappa 抗体,靶向 PLVAP 等。提供 1 mg、5 mg、25 mg 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。

生物试剂 供应商 上海英诺赛图 ↗ 型号 512701 更新 2026-11-12
参考价格区间
¥1,085
含税参考价,实际以配置与渠道报价为准
本条目供应商 上海英诺赛图原厂 1865个条目 进入企业主页

01产品图片

02产品简介

英诺赛图(InnoCyto)的 In Vivo Star Anti-Mouse PLVAP/PV-1 Antibody(克隆 MECA-32) 为大鼠源 IgG2a Kappa 抗体,靶向 PLVAP 等。提供 1 mg、5 mg、25 mg 规格,目录价 ¥1,085 起,仅供科研使用(RUO)。

03产品介绍

规格与货号

512701 | 1 mg | ¥1,085

512702 | 5 mg | ¥2,712

512703 | 25 mg | ¥7,458

Product Details

Application|ELISA, WB, Flow cytometry, IHC, ICC, animal model study

Product Description|In vivo Grade Recombinant Anti-mouse PLVAP/PV-1 Monoclonal Antibody

Regulatory Status|RUO

Endotoxin

Storage Conditions|4ºC

Recommended Usage|This product is suitable for in vivo animal use. Optimal amounts need to be determined empirically for each experiment.

See All Formats|Clone MECA-32

Background Information

Plasmalemma Vesicle-Associated Protein (PLVAP), also known as PV-1, is an endothelial-specific membrane glycoprotein that plays a critical role in regulating vascular permeability and the structure of endothelial diaphragms. It was first identified as a major component of the stomatal and fenestral diaphragms, thin filtration-like structures found at the openings of caveolae, fenestrae, and transendothelial channels in continuous and fenestrated capillaries. These structures are important for controlling the exchange of plasma components between the blood and surrounding tissues, thereby maintaining vascular homeostasis.

Structurally, PLVAP is a type II transmembrane protein composed of a short N-terminal cytoplasmic domain, a single transmembrane helix, and a large extracellular C-terminal region. The extracellular domain forms homodimers and undergoes extensive glycosylation, which contributes to the formation of the characteristic diaphragm-like meshwork in endothelial cells. PLVAP is highly expressed in fenestrated and sinusoidal endothelia, especially in organs such as the liver, endocrine glands, and kidney glomeruli, where rapid molecular exchange is required. In contrast, it is absent or expressed at very low levels in the brain, consistent with the tight endothelial barrier properties of the blood–brain barrier.

PLVAP does not have a single defined ligand in the classical sense but functions as part of a structural complex mediating endothelial barrier selectivity and transcellular transport. Its expression is dynamically regulated by vascular endothelial growth factor (VEGF) and other angiogenic or inflammatory cues. Under pathological conditions, PLVAP expression can be upregulated, leading to increased vascular leakiness and tissue edema. Elevated PLVAP is observed in inflammatory disorders, septic shock, and tumor vasculature, where it contributes to the characteristic leakiness of tumor-associated vessels.

In disease contexts, PLVAP acts as both a biomarker and potential therapeutic target. In cancer, its upregulation marks tumor neovasculature, making it attractive for targeted drug delivery or imaging. Studies suggest that blocking or modulating PLVAP function could reduce pathological vascular permeability without completely disrupting normal endothelial function. Additionally, engineered antibodies or antibody-drug conjugates targeting PLVAP may allow selective delivery of therapeutics to tumor-associated endothelium while sparing healthy vasculature. Beyond oncology, understanding PLVAP biology holds promise for developing therapies to regulate vascular leakage in inflammatory and ischemic diseases, offering opportunities to restore endothelial integrity and improve tissue outcomes.

Data Sheets

Cat # Size Price Quantity 5127011 mg Add to Cart5127025 mg Add to Cart51270325 mg Add to Cart

04完整参数表

参数由厂商资料整理,采购前请以最终报价单与技术协议为准。

包装规格1 mg
CloneMECA-32
Host SpeciesCHO cells
ReactivityMouse
FormatLiquid
Target NamePLVAP, Plasmalemma vesicle-associated protein, PV-1, PV1 FELS
Product DescriptionIn vivo Grade Recombinant Anti-mouse PLVAP/PV-1 Monoclonal Antibody
IsotypeRat IgG2a Kappa
Antibody TypeRecombinant
Regulatory StatusRUO
Purity>95% by reducing SDS-PAGE
Storage Conditions4ºC
GradeIn vivo
Recommended UsageThis product is suitable for in vivo animal use. Optimal amounts need to be determined empirically for each experiment.
RRIDAB_3739401
目录价¥1,085

05荣誉与资质

该品牌暂未上传荣誉证书与资质文件。以下是平台可核验的公开信息,未上传项如实标注,不做推断。

  • 营业执照未上传
  • 品牌授权未上传
  • 产品检测报告未上传
会员身份
收费会员
经营身份
原厂
成立年份
2020 年
所在地
上海
收录条目
1865 个
平台核验
平台代管
向品牌方索取资质文件

06品牌与供应商

上海英诺赛图 原厂
InnoCyto

以可信赖的细胞研究试剂,助力科研突破

进入企业主页
1865 本目录条目
产地 / 总部上海市浦东新区
成立年份2020 年
本目录主营生化试剂 / 蛋白与抗体

InnoCyto(上海英诺赛图生物科技有限公司)致力于通过开发高质量细胞分析试剂,加速科学发现进程。公司为研究人员提供细胞层面探索所需的工具,推动免疫学、肿瘤学等多领域的研究创新。 核心团队拥有丰富的行业经验,曾参与全球头部生命科学公司的标杆项目搭建,深刻理解工业界与学术研究的前沿需求。试剂从设计之初即以精确性、一致性、高性能为核心标准,让科学家能把精力集中在最核心的研究工作上。 公司将深厚的科学积累与对品质的严格承诺相结合,力争成为全球研究人员信赖的合作伙伴。产品线覆盖经验证的一抗与二抗、同型对照、生物类似药抗体、重组蛋白、细胞因子、免疫检测试剂盒及配套试剂,并提供重组蛋白/抗体表达与标记偶联服务。

售后与服务

品牌资料由厂商公开信息与授权渠道核对整理;条目参数与价格以最终报价单为准。

引用此条目 产品目录 · 更新于 2026-11-12
科研在线(TeleVM). In Vivo Star Anti-Mouse PLVAP/PV-1 Antibody(512701)[EB/OL]. 产品目录, 2026-11-12. https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-plvap-pv-1-antibody.html.
TeleVM. (2026, November 12). In Vivo Star Anti-Mouse PLVAP/PV-1 Antibody(512701). 产品目录. https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-plvap-pv-1-antibody.html
@misc{biocsp_item_in_vivo_star_anti_mouse_plvap_pv_1_antibody,
  title        = {In Vivo Star Anti-Mouse PLVAP/PV-1 Antibody(512701)},
  author       = {{科研在线}},
  year         = {2026},
  howpublished = {产品目录},
  note         = {更新于 2026-11-12,产品目录},
  url          = {https://www.suprotek.cn/products/item/in-vivo-star-anti-mouse-plvap-pv-1-antibody.html}
}

GB/T 7714 用于中文论文与报告;APA 7 用于英文期刊;BibTeX 可直接导入 Zotero、EndNote 或 LaTeX。

许可:CC BY-NC 4.0 · 转载注明来源
获取正式报价

In Vivo Star Anti-Mouse PLVAP/PV-1 Antibody

提交后由平台转给品牌方,通常 1 个工作日内联系。不需要注册。